• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同病因疗法方案在青少年肺结核治疗中的应用]

[Use of different regimes of etiopathogenetic therapy in pulmonary tuberculosis in adolescents].

作者信息

Pavlova M V

出版信息

Probl Tuberk. 1995(5):30-2.

PMID:7567888
Abstract

Clinical parameters were assessed in 178 adolescents aged 15-17 with pulmonary tuberculosis. Half of them exhibited changes in the blood picture, immunological E-RFC suppression, enhanced lipid peroxidation. The above disturbances and x-ray evidence served the basis for differential approach to administration of etiotropic treatment. 35 patients received prednisolone in combined therapy. 42, 25 and 51 patients were given olifen, sodium thiosulfate and tuberculin, respectively. 25 patients underwent plasmapheresis. Oriented use of etiopathogenetic therapy raised the efficacy of treatment. Clinical effects went in parallel with cellular response normalization and lipid peroxidation.

摘要

对178名15至17岁的青少年肺结核患者进行了临床参数评估。其中一半患者出现血液图像改变、免疫性E-RFC抑制、脂质过氧化增强。上述紊乱和X线证据为病因治疗的差异化给药方法提供了依据。35例患者在联合治疗中接受了泼尼松龙。分别有42例、25例和51例患者接受了奥利芬、硫代硫酸钠和结核菌素治疗。25例患者接受了血浆置换。病因疗法的定向使用提高了治疗效果。临床效果与细胞反应正常化和脂质过氧化平行。

相似文献

1
[Use of different regimes of etiopathogenetic therapy in pulmonary tuberculosis in adolescents].[不同病因疗法方案在青少年肺结核治疗中的应用]
Probl Tuberk. 1995(5):30-2.
2
[Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis].[抗氧化剂在慢性破坏性肺结核患者联合治疗中的应用]
Ter Arkh. 1994;66(11):54-6.
3
[Pathogenetic therapy of pulmonary tuberculosis in adolescents].青少年肺结核的发病机制治疗
Probl Tuberk. 1994(3):19-21.
4
[Antioxidant treatment of pulmonary tuberculosis in patients with chronic alcoholism].[慢性酒精中毒患者肺结核的抗氧化治疗]
Probl Tuberk. 1992(5-6):28-30.
5
[Comparative effectiveness of etiopathogenetic therapy in adolescents with destructive pulmonary tuberculosis].[病因疗法对青少年破坏性肺结核的比较疗效]
Probl Tuberk. 1994(2):45-6.
6
[Feasibility of pathogenetic treatment of pulmonary tuberculosis patients with and without complicating diseases].[伴有和不伴有并发症的肺结核患者病因治疗的可行性]
Probl Tuberk. 1983 Apr(4):20-5.
7
[Efficacy of glucocorticoids in the combined treatment of destructive pulmonary tuberculosis].糖皮质激素在毁损型肺结核联合治疗中的疗效
Probl Tuberk. 1983 Feb(2):44-7.
8
[Immediate and late results of complex antibacterial therapy of pulmonary tuberculosis in children and adolescents in combination with tuberculin PPD-L or prodigiozan].[儿童和青少年肺结核联合结核菌素PPD-L或灵菌红素进行综合抗菌治疗的近期和远期结果]
Probl Tuberk. 1982 Oct(10):46-50.
9
[Treatment of tuberculosis in children and adolescents with antibacterial preparations combined with tuberculin].[用抗菌制剂联合结核菌素治疗儿童和青少年结核病]
Probl Tuberk. 1974(8):46-50.
10
[Very high frequency electromagnetic irradiation in multimodal treatment of patients with disseminated infiltrative pulmonary tuberculosis].[甚高频电磁辐射在播散性浸润型肺结核患者多模式治疗中的应用]
Probl Tuberk. 2001(2):11-2.